Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 USD | -4.72% | +12.02% | +21.37% |
07-09 | BioCryst Pharmaceuticals Says Orladeyo Approved in Peru | MT |
07-03 | Island Pharmaceuticals Acquiring Clinical-Stage Antiviral Molecule | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.37% | 1.5B | |
+20.03% | 126B | |
+23.61% | 117B | |
+22.68% | 27.52B | |
-18.07% | 20.87B | |
-13.97% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- BCRX Stock
- News BioCryst Pharmaceuticals, Inc.
- BioCryst Pharmaceuticals Partners With Er-Kim Pharmaceuticals to Commercialize Orladeyo in Turkey